- Latest week
- 17 Jul 2026
- Close
- 4.420000
- Fair value
- 11.986337
- Next-week expectancy
- Negative 40.05%
BOLT Chart Pack
Bolt Biotherapeutics
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, BOLT fell 12.65%, moving from 5.06 to 4.42. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -22.31 and has softened across the 12-week window. Market Dynamics is -0.49 on the latest week. Next-week expectancy is negative at 40.05% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 4.42
- 12-Week Change
- -12.65%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 40.05%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -22.31
- Market Dynamics
- -0.49
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 4.42
- 12-Week Change
- -12.65%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 40.05%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -22.31
- Market Dynamics
- -0.49
Over the latest 12 completed weeks ending 2026-07-17, BOLT fell 12.65%, moving from 5.06 to 4.42. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -22.31 and has softened across the 12-week window. Market Dynamics is -0.49 on the latest week. Next-week expectancy is negative at 40.05% based on similar historical setup states.
Industry Peers
United States equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| NXTC NextCure Inc | NASDAQ | 17 Jul 2026 | 2.00 | 9.90 | 1.70 | 5.99 | 199.50% |
| JSPR Jasper Therapeutics Inc | NASDAQ | 17 Jul 2026 | 0.60 | 1.03 | 0.58 | 0.89 | 47.50% |
| OSRH OSR Holdings Inc | NASDAQ | 17 Jul 2026 | 0.33 | 0.51 | 0.33 | 0.47 | 43.18% |
| ATAI ATAI Life Sciences BV | NASDAQ | 17 Jul 2026 | 5.10 | 7.22 | 4.81 | 7.22 | 41.57% |
| COAG Hemab Therapeutics Holdings, Inc. Common Stock | NASDAQ | 17 Jul 2026 | 38.39 | 50.11 | 37.99 | 49.29 | 28.39% |
| EVGN Evogene | NASDAQ | 17 Jul 2026 | 0.50 | 0.68 | 0.44 | 0.63 | 25.80% |
| MRVI Maravai Lifesciences Holdings Inc | NASDAQ | 17 Jul 2026 | 6.00 | 7.26 | 6.00 | 7.24 | 20.63% |
| IOVA Iovance Biotherapeutics Inc | NASDAQ | 17 Jul 2026 | 4.16 | 5.13 | 3.76 | 5.00 | 20.19% |
| ENTX Entera Bio Ltd | NASDAQ | 17 Jul 2026 | 1.65 | 2.09 | 1.57 | 1.98 | 20.00% |
| VYNE Vyne Therapeutics Inc | NASDAQ | 17 Jul 2026 | 0.64 | 0.79 | 0.64 | 0.76 | 19.84% |
| DYAI Dyadic International Inc | NASDAQ | 17 Jul 2026 | 1.06 | 1.34 | 0.98 | 1.26 | 18.87% |
| ANL Adlai Nortye Ltd. American Depositary Shares | NASDAQ | 17 Jul 2026 | 9.80 | 11.90 | 8.88 | 11.53 | 17.65% |
| SLN Silence Therapeutics PLC | NASDAQ | 17 Jul 2026 | 8.98 | 11.19 | 8.91 | 10.50 | 16.93% |
| ACTU Actuate Therapeutics, Inc. Common stock | NASDAQ | 17 Jul 2026 | 1.25 | 1.95 | 1.25 | 1.44 | 15.20% |
| HRTX Heron Therapeuti | NASDAQ | 17 Jul 2026 | 0.41 | 0.50 | 0.39 | 0.47 | 14.80% |
| YDES YD Bio Ltd | NASDAQ | 17 Jul 2026 | 2.15 | 2.50 | 1.99 | 2.45 | 13.95% |